Collectively, we identified that 1p loss decreased FUBP1 protein expression, which was associated with down-regulation of ribosome biogenesis and translation processes, and ultimately with weakened tumor proliferation and a favorable outcome for patients with CDC (Fig. 3M). Here, FUBP1 is linked to neoplasm.